Answer:
No
Explanation:
If the earth was tilted, there would be small changes in temperature, but there will be no seasons. The Earth's axis is now inclined at around 24 degrees. This is the main reason for the changing of the seasons. The Northern Hemisphere is in the warm season when the Earth is slanted toward the sun, and the Northern Hemisphere is in the cold season when the Earth is slanted away from the sun. The cycle repeats itself every year because the Earth rotates around the sun at a known and generally constant rate. The sun is higher in the sky during the warm season, making it warmer, and lower in the sky during the cool season, making it colder.
Hope this helps :)
-jp524
Its simple.. cereal, salad,soup... the teacher wants you to have three common mixtures because the teacher wants to see if you know what things are mixtures in your life. Why i choose CSS/ Cereal,salad,soup because You can drain the milk or take out the cereal.. from cereal, and with a salad you can take out one of the things Ex. Carrot, tomato, chicken, cheese (very hard but you can do it) e.t.c. and soup because you can take out the veggies or meat or noodles.
It is very important because it controls behaviors essential to the life, such as the desire to eat and drink. ... The cingulate gyrus is located in a fold of the brain, and is involved in sensory input for emotions and regulating aggressive behavior. The diencephalon includes the thalamus and hypothalamus.
Answer:
Abstract
Down syndrome (DS) is associated with aberrations in genetic, morphological, biochemical and physiological characteristics. A number of genes located on human chromosome 21 (HSA21) encode proteins which are thought to be involved in numerous metabolic pathways, e.g., phosphofructokinase, cystathionine β-synthase etc. Perturbations of the metabolic pathways may lead to altered drug metabolism in DS individuals. We present a review of metabolic aberrations linked to HSA21 genes in DS. We particularly focus on drug disposition, efficacy, sensitivity and toxicity of anti-leukaemic agents including methotrexate, glucocorticoids, anthracyclines and cytarabine in DS leukaemia. The different outcomes of therapy due to differential drug response, varied drug toxicity and treatment related mortality in DS leukaemia is a subject of much research and speculation. Altered drug response in DS individuals may stem from differences in pharmacokinetics, pharmacodynamics and pharmacogenetics. Further large-cohort studies in different age groups dissecting metabolic and molecular pathways involved in drug response may increase our understanding in this regard and stipulate pharmacotherapies in DS.